Extratympanic electrocochleography: diagnostic and predictive value

To define the clinical value of extratympanic electrocochleography (ECoG) in the diagnosis of Meniere's disease.

Retrospective case review.

An otology/neurotology referral center.

A group of 252 patients with symptoms consistent with Meniere's disease and 20 normal-hearing control subjects.

All patients underwent audiologic testing and extratympanic ECoG at the time of initial evaluation and, when possible, following treatment.

Audiologic thresholds and summating and action potential ratios (SP:AP).

Patients were classified into definite, probable, possible, and bilateral Meniere's disease groups according to American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) guidelines. The definite Meniere's group demonstrated an elevated SP:AP ratio in 74% of cases, the possible Meniere's group in 64%, and the bilateral group demonstrated elevated ratios in both ears in 66%. Contralateral ears produced elevated ratios in 42% for unilateral cases, whereas 40% of these ears reported at least one contralateral symptom. All 40 control ears were normal (SP:AP > or = 0.50). Results statistically correlated (p = 0.004) with the Meniere's staging system set forth in the 1995 AAO-HNS guidelines. No correlation was found between ECoG results and disease duration. Although 72% of the 86 follow-up patients reported complete or substantial vertigo control, changes from initial ECoG results did not specifically correlate to vertigo, tinnitus, or aural fullness improvement.

Extratympanic ECoG can be useful in the diagnosis of Meniere's disease, lending promise to possible cases where objective audiologic data are lacking. Each testing center should study its own results to establish meaningful parameters and confidence levels.